FINHUB Insights

TECH · Q2 FY26 · Oct 1 – Dec 31, 2025

Bio-Techne Q2 FY26: where the revenue came from and where it went

Bio-Techne Q2 FY26: revenue $0.30B (+0% year over year). Net profit $0.04B. Largest cohort Consumables $0.24B. The whole income statement as a sankey diagram from the SEC filing.

Period
Oct 1 – Dec 31, 2025
Reported
Feb 4, 2026 10-Q
Sankey diagram of Bio-Techne's income statement for Q2 FY26: revenue of $0.30 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.30B +0% year over year
Gross profit$0.19B 65% margin
Operating profit$0.05B 18% margin
Net profit$0.04B 13% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Dec 31, 2025).
ItemValueShare of revenueYear over year
Revenue 0.30 100% +0%
Consumables 0.24 79% +2%
Instruments 0.03 10% −4%
Services 0.02 7% −18%
Royalty 0.01 3% +5%
Cost of revenue−0.1135%
Gross profit0.1965% margin−1pp
SG&A−0.1138%−2pp
Other−0.028%+0pp
Operating profit0.0518% margin+2pp
Tax−0.01
Interest & other costs−<0.01
Net profit0.0413%+1pp
Filing on EDGAR More quarters of TECH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.